Cholinergic involvement in Alzheimer's disease. A link with NGF maturation and degradation.
about
Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersΒ-amyloid 1-42 oligomers impair function of human embryonic stem cell-derived forebrain cholinergic neuronsNeuroregeneration in neurodegenerative disorders.A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression.Impaired nerve growth factor homeostasis in patients with bipolar disorder.Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease.Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease.LPS-induced proNGF synthesis and release in the N9 and BV2 microglial cells: a new pathway underling microglial toxicity in neuroinflammationproNGF/NGF mixtures induce gene expression changes in PC12 cells that neither singly produces.Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device.Presence of proNGF-sortilin signaling complex in nigral dopamine neurons and its variation in relation to aging, lactacystin and 6-OHDA insults.Whole-Brain Monosynaptic Afferent Inputs to Basal Forebrain Cholinergic System.Time-Dependent Nerve Growth Factor Signaling Changes in the Rat Retina During Optic Nerve Crush-Induced Degeneration of Retinal Ganglion Cells.The neurotrophins and their role in Alzheimer's disease.Nerve growth factor: basic studies and possible therapeutic applications.The effect of neuropeptide Y on cell survival and neurotrophin expression in in-vitro models of Alzheimer's disease.PROneurotrophins and CONSequences.The Emerging Therapeutic Role of NGF in Alzheimer's Disease.Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease.Neuroprotective effect of neuropeptide Y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production.Non-noxious skin stimulation activates the nucleus basalis of Meynert and promotes NGF secretion in the parietal cortex via nicotinic ACh receptorsRetrogradely Transported TrkA Endosomes Signal Locally within Dendrites to Maintain Sympathetic Neuron SynapsesPlatelet-derived nerve growth factor supports the survival of cholinergic neurons in organotypic rat brain slicesSenescence-accelerated Mice (SAMs) as a Model for Brain Aging and Immunosenescence.Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease.Sex Differences in Risk for Alzheimer's Disease Related to Neurotrophin Gene Polymorphisms: The Cache County Memory Study.Vascular and neuronal protection induced by the ocular administration of nerve growth factor in diabetic-induced rat encephalopathy.Ocular nerve growth factor administration counteracts the impairment of neural precursor cell viability and differentiation in the brain subventricular area of rats with streptozotocin-induced diabetes.Association between nerve growth factor gene polymorphism and executive dysfunction in Japanese patients with early-stage Alzheimer's disease and amnestic mild cognitive impairment.Characterizing serum metabolic alterations of Alzheimer's disease and intervention of Shengmai-San by ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry.Swedish Nerve Growth Factor Mutation (NGFR100W) Defines a Role for TrkA and p75NTR in Nociception.Asparagus cochinchinensis stimulates release of nerve growth factor and abrogates oxidative stress in the Tg2576 model for Alzheimer's disease.Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer's Disease Prevention.The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
P2860
Q27025573-8FD3FAA2-7F0E-41E4-81CA-A3D709671A68Q28744126-0859EBE1-AC25-4A05-8E0C-20720F31BB86Q31020342-3F40163C-01E9-41A2-A1CD-306B78797C09Q34083364-2081B665-088E-4BFC-907C-3674C59B62F8Q34141881-3575E2EB-C586-4FE9-A3CE-6BA10916F6FEQ34366768-D58B4776-7D5D-4244-A0DF-785D2E2D3464Q34575780-ECFBFF30-B87D-4BE8-AA65-46F576421B97Q34989278-60D98611-CA81-4CF7-A8DF-B6402C9E25DFQ35142604-1DBCB639-34ED-494A-9276-9993F3168948Q35186435-B27227B4-CCB6-44DD-B8F8-22E1227B8737Q37073096-2663CC0E-8EB0-45E2-A016-7ACC3F549CA9Q37091907-23C3E034-3000-472C-96DF-886BE289D944Q37323324-93F921A8-3206-41C5-ABFF-C6230B541B7BQ37631533-EBD8F6B7-D94A-4C89-BA51-A7540271E4BBQ38015342-0F451DEF-C795-4978-80D1-EFD9BDDD5132Q38115344-D6077216-4CE6-4C1D-B9CC-4F1EC706C2EFQ38229754-E5CF7839-3536-4C08-B9A2-8E24C881BE95Q38689347-C3E4D31C-0D5A-4C85-9D4D-E64A5B9D1E9AQ38708387-79D7DA51-B92D-4A63-A7C9-0F06689AB2FAQ39388222-985219DC-4D99-4115-A5B9-EEBDC40E49D7Q39586898-A2BC4248-A57C-40E7-9A41-E7CBE97BE506Q41161678-7A2A899C-1041-4D7C-8ACE-70E7B9D5BAF7Q41460503-E584F117-4CA0-40E5-BF90-647B5415F63FQ41978154-9C8BBAF8-3F8A-4CAB-A9DC-0FB3BD4F50A1Q42018503-B929355A-0100-415F-B133-CE11B57261E9Q42515963-0A48A028-245C-43ED-B5C2-2874F6EA7D36Q47765317-52D941D6-0E9F-4C7B-8A03-5C844F8586B9Q48110989-C79ED195-5CB7-4272-84AD-A1DDB2241868Q48303276-E0AF3F46-3C08-4A7C-89CE-26812CB15A09Q48678719-B549183E-74A3-48A0-B3E6-B118BDA5C6E4Q50446511-EBDFFC7E-D9D3-471C-935F-24A060EFC6EBQ52684421-4549252B-2EFC-4C24-84DB-AD94A464D80FQ54918153-F4F84924-B465-477E-BBD6-C72DAE0E4AD5Q55090853-A4F6C720-BC8D-4BCE-B1FD-04488E34F3F0Q57177786-958A915A-E825-41AB-977F-6AED8BE4FC4F
P2860
Cholinergic involvement in Alzheimer's disease. A link with NGF maturation and degradation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cholinergic involvement in Alz ...... GF maturation and degradation.
@en
Cholinergic involvement in Alz ...... GF maturation and degradation.
@nl
type
label
Cholinergic involvement in Alz ...... GF maturation and degradation.
@en
Cholinergic involvement in Alz ...... GF maturation and degradation.
@nl
prefLabel
Cholinergic involvement in Alz ...... GF maturation and degradation.
@en
Cholinergic involvement in Alz ...... GF maturation and degradation.
@nl
P2093
P1476
Cholinergic involvement in Alz ...... GF maturation and degradation.
@en
P2093
A Claudio Cuello
M Florencia Iulita
Martin A Bruno
Simon Allard
Wanda Leon
P2888
P304
P356
10.1007/S12031-009-9238-Z
P577
2009-08-13T00:00:00Z